Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
Year: 2008
Type: article
Institutions: Sanofi (France), Inserm, Université de Lille, Institut Pasteur de Lille
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: rimonabant, cannabinoid CB1 receptor antagonist, atherosclerosis, LDL receptor-deficient mice, Western diet, dietary intake, serum cholesterol, MCP-1, IL-12, inflammatory cytokines, macrophage recruitment, peritoneal macrophages, anti-inflammatory activity, aortic atherosclerotic lesions, pair feeding, lipopolysaccharide
Open Access status: closed
OpenAlex ID: W2031828723
